Product
Supplier
Encyclopedia
Inquiry
Edaravone buy - large image1
Edaravone buy - image1

Edaravone

GMP COA 2 Inquiries

Unit Price: Get Latest Price
CAS No.:

89-25-8

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Shanghai

Brand:

Simcere

Packaging:

5kg/Cardboard Drum

Price valid (until):

2025-01-31

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Diosmectite,Bedaquiline FuMarate,Iguratimod,Edoxaban Tosylate,Edaravone,Borneol

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Introduction

    Edaravone is a new type of free radical scavenger. It was first launched in Japan in April 2001 and is mainly used clinically to treat ischemic stroke. Edaravone exists in the form of anions and can donate one electron to free radicals to achieve the purpose of scavenging free radicals. Because its molecular structure contains lipophilic groups, it can easily pass through the blood-brain barrier to reach the brain tissue, and has a protective effect on nerve cell damage caused by cerebral ischemia.

    Mechanism of action

    The main mechanisms of action of edaravone on nerve cells include scavenging oxygen free radicals to inhibit lipid peroxidation, regulating inflammatory factors, and inhibiting cell apoptosis. With the in-depth study of edaravone, it was found that in addition to treating acute cerebral ischemia, edaravone has a therapeutic effect on other diseases of the nervous system that involve oxidative stress. In addition, edaravone also has a protective effect on other organs outside the nervous system. Edaravone is currently mainly used to treat ischemic stroke, and its clinical application in other aspects is relatively small.

    Indications

    It is suitable for improving neurological symptoms, daily living activities and functional disorders caused by acute cerebral infarction. Drug Interactions: Combination with cefazolin, piperacillin, cefotiam, etc. may aggravate renal failure. Mixing with potassium canrenoate or anti-epileptic drugs such as diazepam and phenytoin sodium may produce turbidity.

    Items Specifications
    Melting point  126-128 °C(lit.)
    Boiling point  287 °C265 mm Hg(lit.)
    form  Crystalline Powder
    color  Yellow to beige
    Water Solubility  3 g/L (20 ºC)

    Certificates

    Basic Info
    Product Name:

    Edaravone

    Other Name:

    3H-Pyrazol-3-one,2,4-dihydro-5-methyl-2-phenyl-;2-Pyrazolin-5-one,3-methyl-1-phenyl-;2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one;C.I. Developer 1;Developer Z;1-Phenyl-3-methyl-2-pyrazolin-5-one;1-Phenyl-3-methyl-5-pyrazolone;Norphenazone;3-Methyl-1-phenylpyrazolin-5-one;3-Methyl-1-phenyl-2-pyrazoline-5-one;3-Methyl-1-phenyl-5-pyrazolone;1-Phenyl-3-methyl-5-pyrazolinone;3-Methyl-1-phenyl-2-pyrazolin-5-one;Norantipyrine;MCI 186;Edaravone;1-Phenyl-3-methyl-5-oxopyrazole;5-Methyl-2-phenylpyrazol-3-one;3-Methyl-1-phenylpyrazol-5(4H)-one;Radicut;3-Methyl-1-phenyl-4,5-dihydropyrazol-5-one;NSC 12;Methylphenylpyrazolone;NSC 26139;NCI-C 03952;NSC 2629;Edarabone;3-Methyl-1-phenyl-1H-pyrazol-5-one;3-Methyl-1-phenyl-4,5-dihydropyrazole-5-one;1-Phenyl-3-methyl-1H-4,5-dihydropyrazol-5-one;5-Methyl-2-phenyl-2H-pyrazol-3(4H)-one;3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one;5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one;3-Methyl-1-phenyl-4,5-dihydro-1H-pyrazol-5-one;Phenylmethyl pyrazolone;Radicava;4,5-Dihydro-3-methyl-5-oxo-1-phenylpyrazole;Edvaradone;3-Methyl-1-phenylpyrazole-5-one;5-Methyl-2-phenyl-2,4-dihydropyrazol-3-one;Edaravon;115566-83-1;12235-58-4;52224-17-6;62495-97-0;72134-66-8;206195-95-1

    CAS No.:

    89-25-8

    Molecular Formula:

    C10H10N2O

    InChIKeys:

    InChIKey=QELUYTUMUWHWMC-UHFFFAOYSA-N

    Molecular Weight:

    174.19900

    Exact Mass:

    174.20

    EC Number:

    201-891-0

    NSC Number:

    758622|26139|2629|12

    DSSTox ID:

    DTXSID9021130

    Color/Form:

    MONOCLINIC PRISMS FROM WATER|WHITE POWDER OR CRYSTALS

    ATC Code:

    N - Nervous system

    HScode:

    2933199090

    Categories:

    Nervous System Drugs

    Characteristics
    PSA:

    32.67000

    XLogP3:

    1.3

    Appearance:

    1-phenyl-3-methyl-5-pyrazolone appears as white to off-white powder or crystals. (NTP, 1992)

    Density:

    1.12

    Melting Point:

    127 °C

    Boiling Point:

    287 °C @ Press: 105 Torr

    Flash Point:

    155.2ºC

    Refractive Index:

    1.606

    Water Solubility:

    H2O: 3 g/L (20 ºC)

    Storage Conditions:

    Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Store protect

    Vapor Pressure:

    less than 0.01 mm Hg at 68 °F (NTP, 1992)

    Toxicity:

    LD50 orl-rat: 3500 mg/kg LONZA# 08FEB79

    PKA:

    7None

    Dissociation Constants:

    7.0

    Air and Water Reactions:

    Insoluble in water.

    Reactive Group:

    Amides and Imides

    Reactivity Profile:

    Amines are chemical bases. They neutralize acids to form salts plus water. These acid-base reactions are exothermic. The amount of heat that is evolved per mole of amine in a neutralization is largely independent of the strength of the amine as a base. Amines may be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. Flammable gaseous hydrogen is generated by amines in combination with strong reducing agents, such as hydrides.

    Hazard Identification

    Classification of the substance or mixture

    Skin irritation, Category 2

    Skin sensitization, Category 1

    Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H315 Causes skin irritation

    H317 May cause an allergic skin reaction

    H411 Toxic to aquatic life with long lasting effects

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    P261 Avoid breathing dust/fume/gas/mist/vapours/spray.

    P272 Contaminated work clothing should not be allowed out of the workplace.

    P273 Avoid release to the environment.

    Response

    P302+P352 IF ON SKIN: Wash with plenty of water/...

    P321 Specific treatment (see ... on this label).

    P332+P317 If skin irritation occurs: Get medical help.

    P362+P364 Take off contaminated clothing and wash it before reuse.

    P333+P317 If skin irritation or rash occurs: Get medical help.

    P391 Collect spillage.

    Storage

    none

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Diosmectite,Bedaquiline FuMarate,Iguratimod,Edoxaban Tosylate,Edaravone,Borneol

    Location:

    No. 109, Changfenghe Road, Jiangbei New District, Nanjing

    Payment Terms:

    100% TT in advance

    Average lead Time:

    30

    Total Annual Revenue:

    Above $100 million

    Total Employees:

    Above 1000

    Year of Establishment:

    2022

    Simcere Pharmaceutical Group Limited (2096.HK) is a pharmaceutical company driven by innovative R&D. We are committed to "providing today's patients with medicines of the future" across the following core therapeutic areas: oncology, central nervous system, autoimmunity and anti-infection. Furthermore, we are also actively expanding our presence in disease areas with significant clinical needs in the future.

    Our industry-leading capabilities and commitment to synergistic innovation have also enabled various strategic collaborations and we are seen as the partner of choice by innovative biopharmaceutical companies, medical institutes, and research teams in China and globally.
  • Inquiry History
    2 Inquiries
    Country Product Purchase Quantity Date Posted
    Vietnam

    Hair dye intermediates

    1000 KG Dec 4, 2024
    Bangladesh

    Butyl Acetate

    1.00 KG Nov 11, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.